Lonza Group Ag Basic Shares Outstanding 2012-2024 | LZAGY

Lonza Group Ag annual/quarterly basic shares outstanding history and growth rate from 2012 to 2024. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
  • Lonza Group Ag basic shares outstanding for the quarter ending December 31, 2024 were $0M, a 0% increase year-over-year.
  • Lonza Group Ag basic shares outstanding for the twelve months ending December 31, 2024 were $0M, a 0% increase year-over-year.
  • Lonza Group Ag annual basic shares outstanding for 2024 were $0.712B, a 3.28% decline from 2023.
  • Lonza Group Ag annual basic shares outstanding for 2023 were $0.736B, a 0.81% decline from 2022.
  • Lonza Group Ag annual basic shares outstanding for 2022 were $0.742B, a 0.04% decline from 2021.
Lonza Group Ag Annual Basic Shares Outstanding
(Millions of US $)
2024 $712
2023 $736
2022 $742
2021 $743
2020 $744
2019 $741
2017 $679
2016 $525
2015 $523
2014 $520
2013 $519
2012 $517
2011 $529
Lonza Group Ag Quarterly Basic Shares Outstanding
(Millions of US $)
2024-12-31
2024-06-30
2023-12-31
2023-06-30
2022-12-31
2022-06-30
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2019-06-30
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2015-06-30
2014-12-31
2014-06-30
2013-12-31
2013-06-30
2012-12-31
2012-06-30
2011-12-31
2011-06-30
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $52.631B $7.468B
Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $230.702B 27.74
Boston Scientific (BSX) United States $154.217B 38.61
Stryker (SYK) United States $145.561B 30.44
EssilorLuxottica (ESLOY) France $133.244B 0.00
Medtronic (MDT) Ireland $107.028B 15.63
Haleon (HLN) United Kingdom $47.943B 27.26
ResMed (RMD) United States $35.287B 26.50
GE HealthCare Technologies (GEHC) United States $31.763B 15.08
Agilent Technologies (A) United States $30.897B 20.41
Terumo (TRUMY) Japan $29.152B 0.00
Koninklijke Philips (PHG) Netherlands $24.100B 17.21
Insulet (PODD) United States $18.209B 77.71
Zimmer Biomet Holdings (ZBH) United States $17.901B 11.50
Baxter (BAX) United States $15.608B 11.66
Smith & Nephew SNATS (SNN) United Kingdom $12.425B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $7.970B 0.00
Lantheus Holdings (LNTH) United States $7.395B 18.18
Bio-Rad Laboratories (BIO) United States $6.728B 22.75
Prestige Consumer Healthcare (PBH) United States $4.111B 19.62
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Perrigo (PRGO) Ireland $3.444B 9.86
ICU Medical (ICUI) United States $3.347B 28.51
Haemonetics (HAE) United States $3.139B 14.77
Envista Holdings (NVST) United States $2.876B 23.90
GN Store Nord (GNNDY) Denmark $2.071B 17.15
QuidelOrtho (QDEL) United States $1.868B 15.64
LeMaitre Vascular (LMAT) United States $1.817B 40.63
AtriCure (ATRC) United States $1.439B 0.00
Green Thumb Industries (GTBIF) United States $1.359B 21.40
Neogen (NEOG) United States $1.224B 15.67
AdaptHealth (AHCO) United States $1.173B 11.30
Kestra Medical Technologies (KMTS) United States $1.159B 0.00
BioLife Solutions (BLFS) United States $1.150B 0.00
InMode (INMD) Israel $0.991B 9.08
Phibro Animal Health (PAHC) United States $0.791B 12.13
Evolus (EOLS) United States $0.774B 0.00
Owens & Minor (OMI) United States $0.632B 5.38
Curaleaf Holdings (CURLF) Canada $0.618B 0.00
CeriBell (CBLL) United States $0.583B 0.00
Valneva SE (VALN) France $0.557B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.539B 0.00
Capricor Therapeutics (CAPR) United States $0.470B 0.00
Tilray Brands (TLRY) Canada $0.442B 0.00
Cresco Labs (CRLBF) United States $0.437B 0.00
Omeros (OMER) United States $0.397B 0.00
Surmodics (SRDX) United States $0.386B 0.00
SNDL (SNDL) Canada $0.355B 0.00
VAREX IMAGING (VREX) United States $0.348B 15.09
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Verano Holdings (VRNOF) United States $0.312B 0.00
Viemed Healthcare (VMD) United States $0.290B 26.18
Sanara MedTech (SMTI) United States $0.288B 0.00
Aurora Cannabis (ACB) Canada $0.265B 47.20
Sanuwave Health (SNWV) United States $0.265B 0.00
Cerus (CERS) United States $0.249B 0.00
ZimVie (ZIMV) United States $0.247B 14.80
Canopy Growth (CGC) Canada $0.234B 0.00
Quanterix (QTRX) United States $0.225B 0.00
OraSure Technologies (OSUR) United States $0.221B 0.00
High Tide (HITI) Canada $0.192B 0.00
Biote (BTMD) United States $0.178B 4.06
Utah Medical Products (UTMD) United States $0.172B 13.83
TriSalus Life Sciences (TLSI) United States $0.165B 0.00
Brainsway (BWAY) Israel $0.164B 51.24
Organigram Global (OGI) Canada $0.149B 0.00
FitLife Brands (FTLF) United States $0.145B 17.91
Jin Medical (ZJYL) China $0.125B 0.00
TerrAscend (TSNDF) Canada $0.118B 0.00
Exagen (XGN) United States $0.113B 0.00
Agape ATP (ATPC) $0.105B 0.00
MacroGenics (MGNX) United States $0.103B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.094B 0.00
Quipt Home Medical (QIPT) United States $0.093B 0.00
Jushi Holdings (JUSHF) United States $0.081B 0.00
Fonar (FONR) United States $0.076B 10.61
Veru (VERU) United States $0.075B 0.00
InterCure (INCR) Israel $0.072B 0.00
Zynex (ZYXI) United States $0.064B 0.00
Cytosorbents (CTSO) United States $0.057B 0.00
United Health Products (UEEC) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.047B 0.00
Apyx Medical (APYX) United States $0.044B 0.00
Modular Medical (MODD) United States $0.041B 0.00
Rockwell Medical (RMTI) United States $0.041B 59.50
Safety Shot (SHOT) United States $0.038B 0.00
United-Guardian (UG) United States $0.037B 11.31
Nephros (NEPH) United States $0.020B 0.00
INLIF (INLF) $0.017B 0.00
Trinity Biotech (TRIB) Ireland $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Allurion Technologies (ALUR) United States $0.011B 0.00
Flora Growth (FLGC) United States $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.007B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Innovative Eyewear (LUCY) United States $0.005B 0.00
Senestech (SNES) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00